Common Stock, Shares, Outstanding of UTAH MEDICAL PRODUCTS INC from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
UTAH MEDICAL PRODUCTS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • UTAH MEDICAL PRODUCTS INC Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 3,204,000, a 6.9% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

UTAH MEDICAL PRODUCTS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 3,204,000 -237,000 -6.9% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 3,216,000 -283,000 -8.1% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 3,281,000 -307,000 -8.6% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 3,335,000 -295,000 -8.1% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 3,441,000 -188,000 -5.2% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 3,499,000 -130,000 -3.6% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 3,588,000 -40,000 -1.1% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 3,630,000 +2,000 +0.06% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 3,629,000 +4,000 +0.11% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 3,629,000 +4,000 +0.11% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 3,628,000 -27,000 -0.74% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 3,628,000 -27,000 -0.74% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 3,625,000 -24,000 -0.66% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 3,625,000 -21,000 -0.58% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 3,655,000 +9,000 +0.25% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 3,655,000 +12,000 +0.33% 31 Dec 2021 10-K/A 28 Mar 2023 2022 FY
Q3 2021 3,649,000 +9,000 +0.25% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 3,646,000 +3,000 +0.08% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 3,646,000 +4,000 +0.11% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 3,643,000 -79,000 -2.1% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q3 2020 3,640,000 -80,000 -2.2% 30 Sep 2020 10-Q/A 09 Nov 2020 2020 Q3
Q2 2020 3,643,000 -76,000 -2% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 3,642,000 -81,000 -2.2% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 3,722,000 +2,000 +0.05% 31 Dec 2019 10-K 26 Mar 2021 2020 FY
Q3 2019 3,720,000 -14,000 -0.38% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 3,719,000 -13,000 -0.35% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 3,723,000 -5,000 -0.13% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 3,720,000 -1,000 -0.03% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 3,734,000 +15,000 +0.4% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 3,732,000 +14,000 +0.38% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 3,728,000 +13,000 +0.35% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 3,721,000 +8,000 +0.22% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q3 2017 3,719,000 -42,000 -1.1% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 3,718,000 -42,000 -1.1% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 3,715,000 -42,000 -1.1% 31 Mar 2017 10-Q 05 May 2017 2017 Q1
Q4 2016 3,713,000 -38,000 -1% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q3 2016 3,761,000 +11,000 +0.29% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 3,760,000 +3,000 +0.08% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 3,757,000 +4,000 +0.11% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 3,751,000 +3,000 +0.08% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q3 2015 3,750,000 +8,000 +0.21% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 3,757,000 +15,000 +0.4% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 3,753,000 -3,000 -0.08% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 3,748,000 +5,000 +0.13% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q3 2014 3,742,000 +4,000 +0.11% 30 Sep 2014 10-Q 04 Nov 2014 2014 Q3
Q2 2014 3,742,000 +14,000 +0.38% 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 3,756,000 +34,000 +0.91% 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 3,743,000 +40,000 +1.1% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q3 2013 3,738,000 +46,000 +1.2% 30 Sep 2013 10-Q 06 Nov 2013 2013 Q3
Q2 2013 3,728,000 +43,000 +1.2% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 3,722,000 +54,000 +1.5% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 3,703,000 +63,000 +1.7% 31 Dec 2012 10-K 12 Mar 2014 2013 FY
Q3 2012 3,692,000 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 3,685,000 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 3,668,000 31 Mar 2012 10-Q 09 May 2012 2012 Q1
Q4 2011 3,640,000 +21,000 +0.58% 31 Dec 2011 10-K 07 Mar 2013 2012 FY
Q4 2010 3,619,000 31 Dec 2010 10-K/A 25 Oct 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.